|
1
|
Dimitriou R, Jones E, McGonagle D and
Giannoudis PV: Bone regeneration: Current concepts and future
directions. BMC Med. 9:662011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schwartz CE, Martha JF, Kowalski P, Wang
DA, Bode R, Li L and Kim DH: Prospective evaluation of chronic pain
associated with posterior autologous iliac crest bone graft harvest
and its effect on postoperative outcome. Health Qual Life Outcomes.
7:492009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim DH, Rhim R, Li L, Martha J, Swaim BH,
Banco RJ, Jenis LG and Tromanhauser SG: Prospective study of iliac
crest bone graft harvest site pain and morbidity. Spine J.
9:886–892. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vo TN, Kasper FK and Mikos AG: Strategies
for controlled delivery of growth factors and cells for bone
regeneration. Adv Drug Deliv Rev. 64:1292–1309. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schindeler A, McDonald MM, Bokko P and
Little DG: Bone remodeling during fracture repair: The cellular
picture. Semin Cell Dev Biol. 19:459–466. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Barnes GL, Kostenuik PJ, Gerstenfeld LC
and Einhorn TA: Growth factor regulation of fracture repair. J Bone
Miner Res. 14:1805–1815. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nauth A, Ristevski B, Li R and Schemitsch
EH: Growth factors and bone regeneration: How much bone can we
expect? Injury. 42:574–579. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Giannoudis PV and Einhorn TA: Bone
morphogenetic proteins in musculoskeletal medicine. Injury.
40(Suppl 3): S1–S3. 2009.
|
|
9
|
Lieberman JR, Daluiski A and Einhorn TA:
The role of growth factors in the repair of bone. Biology and
clinical applications. J Bone Joint Surg Am. 84-A:1032–1044.
2002.PubMed/NCBI
|
|
10
|
Seeherman H and Wozney JM: Delivery of
bone morphogenetic proteins for orthopedic tissue regeneration.
Cytokine Growth. Factor Rev. 16:329–345. 2005. View Article : Google Scholar
|
|
11
|
Argintar E, Edwards S and Delahay J: Bone
morphogenetic proteins in orthopaedic trauma surgery. Injury.
42:730–734. 2011. View Article : Google Scholar
|
|
12
|
Kroese-Deutman HC, Ruhé PQ, Spauwen PH and
Jansen JA: Bone inductive properties of rhBMP-2 loaded porous
calcium phosphate cement implants inserted at an ectopic site in
rabbits. Biomaterials. 26:1131–1138. 2005. View Article : Google Scholar
|
|
13
|
Ishibe T, Goto T, Kodama T, Miyazaki T,
Kobayashi S and Takahashi T: Bone formation on apatite-coated
titanium with incorporated BMP-2/heparin in vivo. Oral Surg Oral
Med Oral Pathol Oral Radiol Endod. 108:867–875. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang HS, La WG, Bhang SH, Lee TJ, Lee M
and Kim BS: Apatite-coated collagen scaffold for bone morphogenetic
protein-2 delivery. Tissue Eng Part A. 17:1–12. 2011. View Article : Google Scholar
|
|
15
|
Fu TS, Chang YH, Wong CB, Wang IC, Tsai
TT, Lai PL, Chen LH and Chen WJ: Mesenchymal stem cells expressing
baculovirus-engineered BMP-2 and VEGF enhance postero-lateral spine
fusion in a rabbit model. Spine J. 15:2036–2044. 2015. View Article : Google Scholar
|
|
16
|
Huang RL, Chen G, Wang W, Herller T, Xie
Y, Gu B and Li Q: Synergy between IL-6 and soluble IL-6 receptor
enhances bone morphogenetic protein-2/absorbable collagen
sponge-induced bone regeneration via regulation of BMPRIA
distribution and degradation. Biomaterials. 67:308–322. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hwang HD, Lee JT, Koh JT, Jung HM, Lee HJ
and Kwon TG: Sequential treatment with SDF-1 and BMP-2 potentiates
bone formation in calvarial defects. Tissue Eng Part A.
21:2125–2135. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zlotnik A and Yoshie O: Chemokines: A new
classification system and their role in immunity. Immunity.
12:121–127. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bleul CC, Farzan M, Choe H, Parolin C, Cla
rk-Lewis I, Sodroski J and Springer TA: The lymphocyte
chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1
entry. Nature. 382:829–833. 1996. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Feng Y, Broder CC, Kennedy PE and Berger
EA: HIV-1 entry cofactor: Functional cDNA cloning of a
seven-transmembrane, G protein-coupled receptor. Science.
272:872–877. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Iannone M, Ventre M, Pagano G, Giannoni P,
Quarto R and Netti PA: Defining an optimal stromal derived factor-1
presentation for effective recruitment of mesenchymal stem cells in
3D. Biotechnol Bioeng. 111:2303–2316. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Naderi-Meshkin H, Bahrami AR, Bidkhori HR,
Mirahmadi M and Ahmadiankia N: Strategies to improve homing of
mesenchymal stem cells for greater efficacy in stem cell therapy.
Cell Biol Int. 39:23–34. 2015. View Article : Google Scholar
|
|
23
|
Granero-Moltó F, Weis JA, Miga MI, Landis
B, Myers TJ, O'Rear L, Longobardi L, Jansen ED, Mortlock DP and
Spagnoli A: Regenerative effects of transplanted mesenchymal stem
cells in fracture healing. Stem Cells. 27:1887–1898. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Otsuru S, Tamai K, Yamazaki T, Yoshikawa H
and Kaneda Y: Circulating bone marrow-derived osteoblast progenitor
cells are recruited to the bone-forming site by the CXCR4/stromal
cell-derived factor-1 pathway. Stem Cells. 26:223–234. 2008.
View Article : Google Scholar
|
|
25
|
Hosogane N, Huang Z, Rawlins BA, Liu X,
Boachie-Adjei O, Boskey AL and Zhu W: Stromal derived factor-1
regulates bone morphogenetic protein 2-induced osteogenic
differentiation of primary mesenchymal stem cells. Int J Biochem
Cell Biol. 42:1132–1141. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu W, Boachie-Adjei O, Rawlins BA,
Frenkel B, Boskey AL, Ivashkiv LB and Blobel CP: A novel regulatory
role for stromal-derived factor-1 signaling in bone morphogenic
protein-2 osteogenic differentiation of mesenchymal C2C12 cells. J
Biol Chem. 282:18676–18685. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Herberg S, Susin C, Pelaez M, Howie RN,
Moreno de Freitas R, Lee J, Cray JJ Jr, Johnson MH, Elsalanty ME,
Hamrick MW, et al: Low-dose bone morphogenetic protein-2/stromal
cell-derived factor-1β cotherapy induces bone regeneration in
critical-size rat calvarial defects. Tissue Eng Part A.
20:1444–1453. 2014. View Article : Google Scholar :
|
|
28
|
Higashino K, Viggeswarapu M, Bargouti M,
Liu H, Titus L and Boden SD: Stromal cell-derived factor-1
potentiates bone morphogenetic protein-2 induced bone formation.
Tissue Eng Part A. 17:523–530. 2011. View Article : Google Scholar
|
|
29
|
Ratanavaraporn J, Furuya H, Kohara H and
Ta bat a Y: Synergistic effects of the dual release of stromal
cell-derived factor-1 and bone morphogenetic protein-2 from
hydrogels on bone regeneration. Biomaterials. 32:2797–2811. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang Q, He QF, Zhang TH, Yu XL, Liu Q and
Deng FL: Improvement in the delivery system of bone morphogenetic
protein-2: A new approach to promote bone formation. Biomed Mater.
7:450022012. View Article : Google Scholar
|
|
31
|
He Q, Zhao Y, Chen B, Xiao Z, Zhang J,
Chen L, Chen W, Deng F and Dai J: Improved cellularization and
angiogenesis using collagen scaffolds chemically conjugated with
vascular endothelial growth factor. Acta Biomater. 7:1084–1093.
2011. View Article : Google Scholar
|
|
32
|
Chen L, He Z, Chen B, Zhao Y, Sun W, Xiao
Z, Zhang J, Yang M, Gao Z and Dai J: Direct chemical cross-linking
of platelet-derived growth factor-BB to the demineralized bone
matrix improves cellularization and vascularization.
Biomacromolecules. 10:3193–3198. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen B, Lin H, Wang J, Zhao Y, Wang B,
Zhao W, Sun W and Dai J: Homogeneous osteogenesis and bone
regeneration by demineralized bone matrix loading with
collagen-targeting bone morphogenetic protein-2. Biomaterials.
28:1027–1035. 2007. View Article : Google Scholar
|
|
34
|
Kolácná L, Bakesová J, Varga F, Kostáková
E, Plánka L, Necas A, Lukás D, Amler E and Pelouch V: Biochemical
and biophysical aspects of collagen nanostructure in the
extracellular matrix. Physiol Res. 56(Suppl 1): S51–S60.
2007.PubMed/NCBI
|
|
35
|
Venugopal J and Ramakrishna S:
Biocompatible nanofiber matrices for the engineering of a dermal
substitute for skin regeneration. Tissue Eng. 11:847–854. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li X, Feng Q, Liu X, Dong W and Cui F:
Collagen-based implants reinforced by chitin fibres in a goat shank
bone defect model. Biomaterials. 27:1917–1923. 2006. View Article : Google Scholar
|
|
37
|
Boccafoschi F, Habermehl J, Vesentini S
and Mantovani D: Biological performances of collagen-based
scaffolds for vascular tissue engineering. Biomaterials.
26:7410–7417. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Park SN, Kim JK and Suh H: Evaluation of
antibiotic-loaded collagen-hyaluronic acid matrix as a skin
substitute. Biomaterials. 25:3689–3698. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jue R, Lambert JM, Pierce LR and Traut RR:
Addition of sulfhydryl groups to Escherichia coli ribosomes by
protein modification with 2-iminothiolane (methyl
4-mercaptobutyrimidate). Biochemistry. 17:5399–5406. 1978.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Geiger M, Li RH and Friess W: Collagen
sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev.
55:1613–1629. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
McQuibban GA, Butler GS, Gong JH, Bendall
L, Power C, Clark-Lewis I and Overall CM: Matrix metalloproteinase
activity inactivates the CXC chemokine stromal cell-derived
factor-1. J Biol Chem. 276:43503–43508. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gomes ME, Sikavitsas VI, Behravesh E, Reis
RL and Mikos AG: Effect of flow perfusion on the osteogenic
differentiation of bone marrow stromal cells cultured on
starch-based three-dimensional scaffolds. J Biomed Mater Res A.
67:87–95. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Richardson TP, Peters MC, Ennett AB and
Mooney DJ: Polymeric system for dual growth factor delivery. Nat
Biotechnol. 19:1029–1034. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kanczler JM, Ginty PJ, White L, Clarke NM,
Howdle SM, Shakesheff KM and Oreffo RO: The effect of the delivery
of vascular endothelial growth factor and bone morphogenic
protein-2 to osteoprogenitor cell populations on bone formation.
Biomaterials. 31:1242–1250. 2010. View Article : Google Scholar
|
|
45
|
Chen FM, Chen R, Wang XJ, Sun HH and Wu
ZF: In vitro cellular responses to scaffolds containing two
microencapulated growth factors. Biomaterials. 30:5215–5224. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Patel ZS, Young S, Tabata Y, Jansen JA,
Wong ME and Mikos AG: Dual delivery of an angiogenic and an
osteogenic growth factor for bone regeneration in a critical size
defect model. Bone. 43:931–940. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Simmons CA, Alsberg E, Hsiong S, Kim WJ
and Mooney DJ: Dual growth factor delivery and controlled scaffold
degradation enhance in vivo bone formation by transplanted bone
marrow stromal cells. Bone. 35:562–569. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Herberg S, Kondrikova G,
Periyasamy-Thandavan S, Howie RN, Elsalanty ME, Weiss L, Campbell
P, Hill WD and Cray JJ: Inkjet-based biopatterning of SDF-1β
augments BMP-2-induced repair of critical size calvarial bone
defects in mice. Bone. 67:95–103. 2014. View Article : Google Scholar : PubMed/NCBI
|
